| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.74e-11 | 17 | 75 | 6 | GO:0005132 | |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 8.31e-05 | 4 | 75 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.14e-04 | 324 | 75 | 7 | GO:0005126 | |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 2.89e-04 | 7 | 75 | 2 | GO:0034634 | |
| GeneOntologyMolecularFunction | cytokine activity | 3.55e-04 | 250 | 75 | 6 | GO:0005125 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 4.93e-04 | 9 | 75 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | tRNA (cytidine) methyltransferase activity | 6.14e-04 | 10 | 75 | 2 | GO:0016427 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 8.97e-04 | 12 | 75 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 1.02e-03 | 547 | 75 | 8 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.10e-03 | 554 | 75 | 8 | GO:0030546 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.57e-03 | 61 | 75 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 1.61e-03 | 16 | 75 | 2 | GO:0035673 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 9.79e-11 | 21 | 75 | 6 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 2.41e-10 | 24 | 75 | 6 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 6.66e-10 | 28 | 75 | 6 | GO:0042501 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 8.91e-09 | 42 | 75 | 6 | GO:0002323 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 4.75e-08 | 55 | 75 | 6 | GO:0043330 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.09e-07 | 63 | 75 | 6 | GO:0043331 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 6.57e-07 | 85 | 75 | 6 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 7.04e-07 | 86 | 75 | 6 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 9.22e-07 | 90 | 75 | 6 | GO:0098586 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.05e-06 | 92 | 75 | 6 | GO:0034340 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.17e-06 | 216 | 75 | 8 | GO:0097696 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 1.82e-06 | 101 | 75 | 6 | GO:0033138 | |
| GeneOntologyBiologicalProcess | humoral immune response | 2.44e-06 | 321 | 75 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 3.31e-06 | 63 | 75 | 5 | GO:0050691 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 3.33e-06 | 112 | 75 | 6 | GO:0140888 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 6.00e-06 | 124 | 75 | 6 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 6.00e-06 | 124 | 75 | 6 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 6.28e-06 | 125 | 75 | 6 | GO:0046425 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 7.72e-06 | 198 | 75 | 7 | GO:0007259 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 1.06e-05 | 137 | 75 | 6 | GO:0033135 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 1.36e-05 | 143 | 75 | 6 | GO:1904892 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.65e-05 | 148 | 75 | 6 | GO:0002286 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.92e-05 | 90 | 75 | 5 | GO:0050688 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | CYBB TRPA1 HTR5A MAOB NAGLU FBXO32 RGS4 IFNA2 IFNA4 IFNA5 IFNA6 RYR3 IFNA17 IFNA21 | 2.16e-05 | 1048 | 75 | 14 | GO:0014070 |
| GeneOntologyBiologicalProcess | B cell differentiation | 9.15e-05 | 201 | 75 | 6 | GO:0030183 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 1.12e-04 | 406 | 75 | 8 | GO:0032943 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 2.10e-04 | 445 | 75 | 8 | GO:0070661 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 3.05e-04 | 251 | 75 | 6 | GO:0002285 | |
| GeneOntologyBiologicalProcess | glutathione transmembrane transport | 3.60e-04 | 8 | 75 | 2 | GO:0034775 | |
| GeneOntologyBiologicalProcess | tripeptide transmembrane transport | 5.76e-04 | 10 | 75 | 2 | GO:0035443 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 6.07e-04 | 398 | 75 | 7 | GO:0046651 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CYBB UBR1 REG3G MTARC2 RGS4 IFNA2 IFNA4 IFNA5 IFNA6 RYR3 TP73 IFNA17 IFNA21 | 6.19e-04 | 1272 | 75 | 13 | GO:1901698 |
| GeneOntologyBiologicalProcess | glutathione transport | 7.02e-04 | 11 | 75 | 2 | GO:0034635 | |
| GeneOntologyBiologicalProcess | otolith development | 7.02e-04 | 11 | 75 | 2 | GO:0048840 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 7.54e-04 | 49 | 75 | 3 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 7.54e-04 | 49 | 75 | 3 | GO:0099633 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 8.81e-04 | 307 | 75 | 6 | GO:0018105 | |
| GeneOntologyBiologicalProcess | tripeptide transport | 9.92e-04 | 13 | 75 | 2 | GO:0042939 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.07e-03 | 319 | 75 | 6 | GO:0018209 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.46e-04 | 29 | 74 | 3 | GO:0097038 | |
| Domain | Interferon_alpha/beta/delta | 4.09e-11 | 17 | 75 | 6 | IPR000471 | |
| Domain | Interferon | 4.09e-11 | 17 | 75 | 6 | PF00143 | |
| Domain | IFabd | 4.09e-11 | 17 | 75 | 6 | SM00076 | |
| Domain | INTERFERON_A_B_D | 4.09e-11 | 17 | 75 | 6 | PS00252 | |
| Domain | - | 4.72e-08 | 50 | 75 | 6 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 5.34e-08 | 51 | 75 | 6 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 5.10e-07 | 74 | 75 | 6 | IPR009079 | |
| Domain | Cyt_b245_heavy_chain | 9.50e-05 | 4 | 75 | 2 | IPR000778 | |
| Domain | MeTrfase | 9.50e-05 | 4 | 75 | 2 | IPR026113 | |
| Domain | Methyltransf_12 | 2.36e-04 | 6 | 75 | 2 | PF08242 | |
| Domain | Methyltransf_12 | 2.36e-04 | 6 | 75 | 2 | IPR013217 | |
| Domain | NAD_binding_6 | 3.30e-04 | 7 | 75 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 3.30e-04 | 7 | 75 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 3.30e-04 | 7 | 75 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 3.30e-04 | 7 | 75 | 2 | IPR013121 | |
| Domain | HAT | 7.01e-04 | 10 | 75 | 2 | IPR003107 | |
| Domain | HAT | 7.01e-04 | 10 | 75 | 2 | SM00386 | |
| Domain | Oxysterol-bd | 1.02e-03 | 12 | 75 | 2 | IPR000648 | |
| Domain | Ferric_reduct | 1.02e-03 | 12 | 75 | 2 | PF01794 | |
| Domain | Oxysterol-bd_CS | 1.02e-03 | 12 | 75 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 1.02e-03 | 12 | 75 | 2 | PF01237 | |
| Domain | Fe3_Rdtase_TM_dom | 1.02e-03 | 12 | 75 | 2 | IPR013130 | |
| Domain | OSBP | 1.02e-03 | 12 | 75 | 2 | PS01013 | |
| Domain | Fd_Rdtase_FAD-bd | 2.60e-03 | 19 | 75 | 2 | IPR017927 | |
| Domain | FAD_FR | 2.60e-03 | 19 | 75 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 2.60e-03 | 19 | 75 | 2 | IPR017938 | |
| Domain | IQ | 4.24e-03 | 81 | 75 | 3 | SM00015 | |
| Domain | FERM_C | 4.86e-03 | 26 | 75 | 2 | PF09380 | |
| Domain | FERM_C | 5.23e-03 | 27 | 75 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 5.23e-03 | 27 | 75 | 2 | IPR018980 | |
| Domain | IQ_motif_EF-hand-BS | 5.69e-03 | 90 | 75 | 3 | IPR000048 | |
| Domain | IQ | 6.23e-03 | 93 | 75 | 3 | PS50096 | |
| Domain | TIG | 6.86e-03 | 31 | 75 | 2 | PF01833 | |
| Domain | PSI | 7.30e-03 | 32 | 75 | 2 | PF01437 | |
| Domain | IPT | 7.30e-03 | 32 | 75 | 2 | IPR002909 | |
| Domain | Plexin_repeat | 7.30e-03 | 32 | 75 | 2 | IPR002165 | |
| Domain | FERM_N | 7.75e-03 | 33 | 75 | 2 | PF09379 | |
| Domain | FERM_N | 7.75e-03 | 33 | 75 | 2 | IPR018979 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 2.53e-11 | 17 | 53 | 6 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 3.78e-11 | 18 | 53 | 6 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 5.51e-11 | 19 | 53 | 6 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 7.85e-11 | 20 | 53 | 6 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.10e-10 | 21 | 53 | 6 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.50e-10 | 22 | 53 | 6 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.50e-10 | 22 | 53 | 6 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 2.03e-10 | 23 | 53 | 6 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 2.03e-10 | 23 | 53 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 2.70e-10 | 24 | 53 | 6 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 2.70e-10 | 24 | 53 | 6 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 2.70e-10 | 24 | 53 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 4.58e-10 | 26 | 53 | 6 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.17e-09 | 30 | 53 | 6 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 1.45e-09 | 31 | 53 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 1.45e-09 | 31 | 53 | 6 | M47964 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.62e-09 | 34 | 53 | 6 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 3.15e-09 | 35 | 53 | 6 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 3.15e-09 | 35 | 53 | 6 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 4.49e-09 | 37 | 53 | 6 | M39785 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 6.92e-09 | 19 | 53 | 5 | MM1571 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 3.76e-08 | 52 | 53 | 6 | M13103 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 5.31e-08 | 55 | 53 | 6 | M11844 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 5.70e-08 | 28 | 53 | 5 | MM1378 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 7.50e-08 | 98 | 53 | 7 | M48247 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.36e-07 | 33 | 53 | 5 | MM1379 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.47e-07 | 65 | 53 | 6 | M272 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.51e-07 | 71 | 53 | 6 | M15913 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 2.96e-07 | 73 | 53 | 6 | M39837 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.03e-07 | 120 | 53 | 7 | M48233 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 3.24e-07 | 39 | 53 | 5 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 4.19e-07 | 41 | 53 | 5 | MM1493 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 4.41e-07 | 78 | 53 | 6 | M973 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 5.94e-07 | 82 | 53 | 6 | M1002 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 7.09e-07 | 136 | 53 | 7 | M42547 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 9.04e-07 | 88 | 53 | 6 | M16004 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.71e-06 | 155 | 53 | 7 | M17411 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.16e-06 | 102 | 53 | 6 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 2.28e-06 | 103 | 53 | 6 | M39434 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 7.36e-06 | 126 | 53 | 6 | M45009 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 7.71e-06 | 127 | 53 | 6 | M42533 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 1.19e-05 | 137 | 53 | 6 | M5669 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.24e-05 | 138 | 53 | 6 | MM15635 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 1.44e-05 | 299 | 53 | 8 | M41727 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.81e-05 | 87 | 53 | 5 | MM15915 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 2.07e-05 | 151 | 53 | 6 | M39801 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 4.04e-05 | 170 | 53 | 6 | M941 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 5.51e-05 | 264 | 53 | 7 | M9809 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 5.76e-05 | 471 | 53 | 9 | M39009 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.11e-04 | 204 | 53 | 6 | M45011 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 3.56e-04 | 37 | 53 | 3 | M45513 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 5.34e-04 | 273 | 53 | 6 | M983 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.34e-03 | 326 | 53 | 6 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.64e-03 | 339 | 53 | 6 | M39736 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.68e-03 | 136 | 53 | 4 | MM14848 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 1.83e-03 | 472 | 53 | 7 | MM14539 | |
| Pathway | WP_CANCER_PATHWAYS | 2.75e-03 | 507 | 53 | 7 | M48302 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 3.34e-03 | 23 | 53 | 2 | MM14804 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 3.63e-03 | 24 | 53 | 2 | M27553 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 3.63e-03 | 24 | 53 | 2 | M636 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 3.94e-03 | 25 | 53 | 2 | MM15269 | |
| Pubmed | 8.14e-14 | 12 | 76 | 6 | 16565497 | ||
| Pubmed | 8.14e-14 | 12 | 76 | 6 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 8.14e-14 | 12 | 76 | 6 | 8760352 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 8.14e-14 | 12 | 76 | 6 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 8.14e-14 | 12 | 76 | 6 | 1886773 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 8.14e-14 | 12 | 76 | 6 | 7530016 | |
| Pubmed | 8.14e-14 | 12 | 76 | 6 | 9794206 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 8.14e-14 | 12 | 76 | 6 | 7684767 | |
| Pubmed | 8.14e-14 | 12 | 76 | 6 | 17451966 | ||
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 8.14e-14 | 12 | 76 | 6 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 8.14e-14 | 12 | 76 | 6 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 8.14e-14 | 12 | 76 | 6 | 3758677 | |
| Pubmed | 8.14e-14 | 12 | 76 | 6 | 8245849 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 1.51e-13 | 13 | 76 | 6 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 1.51e-13 | 13 | 76 | 6 | 2014240 | |
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 18005734 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 12050368 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 1.51e-13 | 13 | 76 | 6 | 2987810 | |
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 1.51e-13 | 13 | 76 | 6 | 6094686 | |
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 19130550 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 1655578 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 2471809 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 22739040 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 8438572 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 9343822 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 9181467 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 1.51e-13 | 13 | 76 | 6 | 23255800 | |
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 7523540 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 1.51e-13 | 13 | 76 | 6 | 18726328 | |
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 19706714 | ||
| Pubmed | 1.51e-13 | 13 | 76 | 6 | 18572754 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 14983024 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 2.64e-13 | 14 | 76 | 6 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 2.64e-13 | 14 | 76 | 6 | 7526537 | |
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 19559726 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 25972534 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 15240719 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 7583919 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 16418394 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 18272764 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 2987811 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 11884139 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 19004943 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 21172865 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 2552026 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 2.64e-13 | 14 | 76 | 6 | 15254193 | |
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 2.64e-13 | 14 | 76 | 6 | 7532202 | |
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 16278001 | ||
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 2.64e-13 | 14 | 76 | 6 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 2.64e-13 | 14 | 76 | 6 | 17517919 | |
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 2.64e-13 | 14 | 76 | 6 | 1381203 | |
| Pubmed | 2.64e-13 | 14 | 76 | 6 | 8345204 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 4.38e-13 | 15 | 76 | 6 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 4.38e-13 | 15 | 76 | 6 | 18339807 | |
| Pubmed | 4.38e-13 | 15 | 76 | 6 | 8786318 | ||
| Pubmed | 4.38e-13 | 15 | 76 | 6 | 15684736 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 4.38e-13 | 15 | 76 | 6 | 8661419 | |
| Pubmed | 4.38e-13 | 15 | 76 | 6 | 9520456 | ||
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 7.00e-13 | 16 | 76 | 6 | 22315404 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 7.00e-13 | 16 | 76 | 6 | 18414664 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 7.00e-13 | 16 | 76 | 6 | 7904170 | |
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 1.08e-12 | 17 | 76 | 6 | 15233997 | |
| Pubmed | 1.08e-12 | 17 | 76 | 6 | 22814248 | ||
| Pubmed | 1.62e-12 | 18 | 76 | 6 | 1905933 | ||
| Pubmed | 2.36e-12 | 19 | 76 | 6 | 7511078 | ||
| Pubmed | 2.36e-12 | 19 | 76 | 6 | 7815507 | ||
| Pubmed | 2.36e-12 | 19 | 76 | 6 | 1385305 | ||
| Pubmed | 2.36e-12 | 19 | 76 | 6 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 2.36e-12 | 19 | 76 | 6 | 1708818 | |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 3.37e-12 | 20 | 76 | 6 | 11694501 | |
| Pubmed | 3.37e-12 | 20 | 76 | 6 | 8764000 | ||
| Pubmed | 4.71e-12 | 21 | 76 | 6 | 9108403 | ||
| Pubmed | 6.46e-12 | 22 | 76 | 6 | 7913356 | ||
| Pubmed | 6.46e-12 | 22 | 76 | 6 | 23100517 | ||
| Pubmed | 6.46e-12 | 22 | 76 | 6 | 16160188 | ||
| Pubmed | 8.72e-12 | 23 | 76 | 6 | 9225992 | ||
| Pubmed | PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response. | 1.16e-11 | 24 | 76 | 6 | 35037428 | |
| Pubmed | 1.53e-11 | 25 | 76 | 6 | 27183626 | ||
| Pubmed | Modulation of HIV-1 transcription by cytokines and chemokines. | 1.53e-11 | 25 | 76 | 6 | 16375755 | |
| Pubmed | Role of HIV-1 Vpu protein for virus spread and pathogenesis. | 1.53e-11 | 25 | 76 | 6 | 18672082 | |
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 1.98e-11 | 26 | 76 | 6 | 38744293 | |
| Pubmed | 1.98e-11 | 26 | 76 | 6 | 9658081 | ||
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.99e-11 | 11 | 76 | 5 | 8389790 | |
| Pubmed | 1.99e-11 | 11 | 76 | 5 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.99e-11 | 11 | 76 | 5 | 6444699 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.99e-11 | 11 | 76 | 5 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.99e-11 | 11 | 76 | 5 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.99e-11 | 11 | 76 | 5 | 15795237 | |
| Pubmed | 1.99e-11 | 11 | 76 | 5 | 9794439 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.99e-11 | 11 | 76 | 5 | 10448195 | |
| Pubmed | 1.99e-11 | 11 | 76 | 5 | 25310498 | ||
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.99e-11 | 11 | 76 | 5 | 19120292 | |
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 2.54e-11 | 27 | 76 | 6 | 30936491 | |
| Pubmed | Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. | 2.54e-11 | 27 | 76 | 6 | 33165593 | |
| Pubmed | Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. | 3.23e-11 | 28 | 76 | 6 | 17277142 | |
| Pubmed | 3.23e-11 | 28 | 76 | 6 | 15481145 | ||
| Pubmed | 3.41e-11 | 12 | 76 | 5 | 22685550 | ||
| Pubmed | 3.41e-11 | 12 | 76 | 5 | 3017340 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 3.41e-11 | 12 | 76 | 5 | 21320124 | |
| Interaction | IFNA5 interactions | 1.56e-08 | 22 | 75 | 5 | int:IFNA5 | |
| Interaction | IFNA1 interactions | 3.11e-07 | 16 | 75 | 4 | int:IFNA1 | |
| Interaction | IFNA6 interactions | 2.74e-06 | 8 | 75 | 3 | int:IFNA6 | |
| Interaction | IFNA13 interactions | 8.00e-06 | 11 | 75 | 3 | int:IFNA13 | |
| Interaction | IFNA2 interactions | 1.06e-05 | 12 | 75 | 3 | int:IFNA2 | |
| Interaction | IFNA4 interactions | 1.61e-05 | 41 | 75 | 4 | int:IFNA4 | |
| Interaction | IFNA14 interactions | 2.68e-05 | 16 | 75 | 3 | int:IFNA14 | |
| Interaction | INSL5 interactions | 6.45e-05 | 58 | 75 | 4 | int:INSL5 | |
| Interaction | METTL2B interactions | 8.31e-05 | 23 | 75 | 3 | int:METTL2B | |
| Cytoband | 9p22 | 2.91e-12 | 25 | 76 | 6 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 6.44e-08 | 124 | 76 | 6 | chr9p21 | |
| Cytoband | 13q32 | 2.08e-04 | 13 | 76 | 2 | 13q32 | |
| GeneFamily | Interferons | 4.05e-10 | 32 | 53 | 6 | 598 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 5.46e-04 | 12 | 53 | 2 | 670 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 1.25e-03 | 18 | 53 | 2 | 812 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 2.02e-08 | 29 | 76 | 5 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 9.56e-08 | 39 | 76 | 5 | M41095 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 1.23e-07 | 80 | 76 | 6 | MM646 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 1.77e-07 | 85 | 76 | 6 | MM684 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.04e-07 | 87 | 76 | 6 | MM652 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 2.28e-06 | 131 | 76 | 6 | MM1127 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 3.64e-06 | 80 | 76 | 5 | MM1229 | |
| Coexpression | GSE25087_TREG_VS_TCONV_FETUS_UP | 2.43e-05 | 198 | 76 | 6 | M4647 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 3.38e-05 | 210 | 76 | 6 | MM751 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP | 4.70e-05 | 328 | 76 | 7 | M854 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 4.81e-05 | 584 | 76 | 9 | MM1080 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 6.52e-05 | 27 | 76 | 3 | M40935 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.09e-04 | 32 | 76 | 3 | M40934 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.31e-04 | 34 | 76 | 3 | M41094 | |
| Coexpression | NABA_MATRISOME | MXRA5 REG3G FNDC8 GPC6 IFNA2 IFNA4 IFNA5 PLXNA2 IFNA6 IFNA17 IFNA21 | 1.75e-04 | 1026 | 76 | 11 | M5889 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.81e-06 | 163 | 76 | 5 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 182 | 76 | 5 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 182 | 76 | 5 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 183 | 76 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 183 | 76 | 5 | 262387ee8d43b96e5f1a77c75124459a506a6172 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 183 | 76 | 5 | c85a707acbcb582912e8ac080a36d05f91cfd7a2 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-05 | 186 | 76 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.14e-05 | 196 | 76 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-05 | 198 | 76 | 5 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| Drug | ABMP | 2.47e-10 | 26 | 76 | 6 | CID000080567 | |
| Drug | gunacin | 7.09e-10 | 14 | 76 | 5 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 1.06e-09 | 15 | 76 | 5 | CID000125229 | |
| Drug | tilorone | 1.70e-09 | 35 | 76 | 6 | CID000005475 | |
| Drug | podophyllin | 3.00e-09 | 18 | 76 | 5 | CID011979494 | |
| Drug | Nyco | 3.00e-09 | 18 | 76 | 5 | CID000071618 | |
| Drug | Yfrkd | 3.98e-09 | 7 | 76 | 4 | CID000129984 | |
| Drug | Chebi:36708 | 7.94e-09 | 8 | 76 | 4 | CID011966289 | |
| Drug | 1hiv | 7.94e-09 | 8 | 76 | 4 | CID005479205 | |
| Drug | formosanin C | 9.13e-09 | 22 | 76 | 5 | CID000073597 | |
| Drug | Hiltonol | 1.16e-08 | 23 | 76 | 5 | CID000431963 | |
| Drug | adefovir dipivoxil | 1.41e-08 | 49 | 76 | 6 | CID000060871 | |
| Drug | cycloferon | 1.47e-08 | 24 | 76 | 5 | CID000038072 | |
| Drug | hycanthone | 1.83e-08 | 25 | 76 | 5 | CID000003634 | |
| Drug | pipobroman | 2.37e-08 | 10 | 76 | 4 | CID000004842 | |
| Drug | inosiplex | 2.76e-08 | 27 | 76 | 5 | CID000037510 | |
| Drug | busulfan | 3.52e-08 | 97 | 76 | 7 | CID000002478 | |
| Drug | flesinoxan | 3.72e-08 | 11 | 76 | 4 | CID000057347 | |
| Drug | poly rI:rC | 4.84e-08 | 30 | 76 | 5 | CID011979660 | |
| Drug | penciclovir | 4.84e-08 | 30 | 76 | 5 | CID000004725 | |
| Drug | DZNep | 4.84e-08 | 30 | 76 | 5 | CID000073087 | |
| Drug | CHEMBL466993 | 6.81e-08 | 32 | 76 | 5 | CID005320808 | |
| Drug | adefovir | 7.27e-08 | 64 | 76 | 6 | CID000060172 | |
| Drug | R 842 | 8.01e-08 | 13 | 76 | 4 | CID000130714 | |
| Drug | carprofen | 9.35e-08 | 34 | 76 | 5 | CID000002581 | |
| Drug | Lanicemine | 1.12e-07 | 14 | 76 | 4 | CID003038485 | |
| Drug | cycloleucine | 1.15e-07 | 69 | 76 | 6 | CID000002901 | |
| Drug | 9-cis-acitretin | 1.36e-07 | 71 | 76 | 6 | CID000041317 | |
| Drug | pyran | 1.45e-07 | 37 | 76 | 5 | CID000033703 | |
| Drug | anagrelide | 1.67e-07 | 38 | 76 | 5 | CID000002182 | |
| Drug | isofagomine lactam | 1.91e-07 | 39 | 76 | 5 | CID000448980 | |
| Drug | vinblastine | 2.26e-07 | 189 | 76 | 8 | CID000013342 | |
| Drug | YNK01 | 2.64e-07 | 17 | 76 | 4 | CID000084071 | |
| Drug | leucovorin | 2.65e-07 | 130 | 76 | 7 | CID000000143 | |
| Drug | 1 ind | 2.80e-07 | 42 | 76 | 5 | CID003037877 | |
| Drug | Sesquimustard | 3.16e-07 | 43 | 76 | 5 | CID000019092 | |
| Drug | AC1L9FQV | 3.24e-07 | 82 | 76 | 6 | CID000444118 | |
| Drug | p203 | 3.39e-07 | 18 | 76 | 4 | CID000019228 | |
| Drug | AC1L9AL3 | 4.47e-07 | 46 | 76 | 5 | CID000441122 | |
| Drug | 2'-deoxy-3'-thiacytidine | 4.61e-07 | 87 | 76 | 6 | CID000003877 | |
| Drug | entecavir | 4.99e-07 | 47 | 76 | 5 | CID000153941 | |
| Drug | Ciluprevir [USAN] | 5.33e-07 | 20 | 76 | 4 | CID006450803 | |
| Drug | val-mCyd | 5.33e-07 | 20 | 76 | 4 | CID006918726 | |
| Drug | L DO | 6.57e-07 | 21 | 76 | 4 | CID000097725 | |
| Drug | trifluorothymidine | 7.56e-07 | 51 | 76 | 5 | CID000006256 | |
| Drug | amantadine | 7.77e-07 | 95 | 76 | 6 | CID000002130 | |
| Drug | famciclovir | 8.34e-07 | 52 | 76 | 5 | CID000003324 | |
| Drug | bropirimine | 8.34e-07 | 52 | 76 | 5 | CID000065457 | |
| Drug | Ampligen | 9.18e-07 | 53 | 76 | 5 | CID000038077 | |
| Drug | AC1L1ZCT | 1.16e-06 | 24 | 76 | 4 | CID000038235 | |
| Drug | m IU | 1.21e-06 | 56 | 76 | 5 | CID006852123 | |
| Drug | LB80380 | 1.37e-06 | 25 | 76 | 4 | CID006480442 | |
| Drug | Lps2 | 1.45e-06 | 58 | 76 | 5 | CID000454710 | |
| Drug | polycytidylic acid | 1.56e-06 | 169 | 76 | 7 | CID000000314 | |
| Drug | AC1L1U53 | 1.72e-06 | 60 | 76 | 5 | CID000060907 | |
| Drug | VX-497 | 1.90e-06 | 27 | 76 | 4 | CID000153241 | |
| Drug | AC1NRD2B | 2.21e-06 | 28 | 76 | 4 | CID005289317 | |
| Drug | AC1L1HZP | 2.37e-06 | 64 | 76 | 5 | CID000004361 | |
| Drug | NM 108 | 2.56e-06 | 29 | 76 | 4 | CID000500901 | |
| Drug | AC1O51IP | 2.76e-06 | 66 | 76 | 5 | CID006450363 | |
| Drug | copolymer 1 | 2.76e-06 | 66 | 76 | 5 | CID003081884 | |
| Drug | medrol | 2.95e-06 | 186 | 76 | 7 | CID000004159 | |
| Drug | N6-methyl-(R)-roscovitine | 3.98e-06 | 71 | 76 | 5 | CID005289296 | |
| Drug | isoflurane | 4.22e-06 | 279 | 76 | 8 | CID000003763 | |
| Drug | AC1L1GHH | 4.88e-06 | 74 | 76 | 5 | CID000003685 | |
| Drug | 2',3'-dideoxycytidine diphosphate | 4.88e-06 | 74 | 76 | 5 | CID000128494 | |
| Drug | tenofovir disoproxil fumarate | 4.93e-06 | 34 | 76 | 4 | CID005481350 | |
| Drug | neopterine | 5.55e-06 | 133 | 76 | 6 | CID000004455 | |
| Drug | lobucavir | 5.55e-06 | 35 | 76 | 4 | CID000060786 | |
| Drug | AC1MMF4B | 5.94e-06 | 77 | 76 | 5 | CID003260010 | |
| Drug | MCNU | 6.23e-06 | 36 | 76 | 4 | CID000071741 | |
| Drug | A809128 | 6.23e-06 | 36 | 76 | 4 | CID003392279 | |
| Drug | mu-I | 6.33e-06 | 78 | 76 | 5 | CID011987863 | |
| Drug | FMAU | 6.96e-06 | 37 | 76 | 4 | CID000072327 | |
| Drug | Zinetac | 7.17e-06 | 80 | 76 | 5 | CID000005039 | |
| Drug | DTIC | 7.62e-06 | 81 | 76 | 5 | CID005281007 | |
| Drug | fotemustine | 7.76e-06 | 38 | 76 | 4 | CID000104799 | |
| Drug | AC1O52EF | 9.98e-06 | 13 | 76 | 3 | CID006450817 | |
| Drug | glycrrhizin | 1.02e-05 | 86 | 76 | 5 | CID000003495 | |
| Drug | dichloromethanediamine | 1.20e-05 | 539 | 76 | 10 | CID005311048 | |
| Drug | Murabutida | 1.28e-05 | 43 | 76 | 4 | CID005362018 | |
| Drug | NSC 312887 | 1.28e-05 | 43 | 76 | 4 | CID000003368 | |
| Drug | C12063 | 1.28e-05 | 429 | 76 | 9 | CID005282055 | |
| Drug | NMMA | 1.58e-05 | 94 | 76 | 5 | CID000170607 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.71e-05 | 162 | 76 | 6 | CID000072363 | |
| Drug | indole alkaloid | 1.74e-05 | 244 | 76 | 7 | CID000005978 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 2.17e-05 | 49 | 76 | 4 | CID000365716 | |
| Drug | Azitidin | 2.18e-05 | 169 | 76 | 6 | CID000005726 | |
| Drug | imidazoquinoline | 2.24e-05 | 101 | 76 | 5 | CID005351568 | |
| Drug | 5H-purin-2-amine | 2.35e-05 | 102 | 76 | 5 | CID000409844 | |
| Drug | cimetidine | 3.01e-05 | 179 | 76 | 6 | CID000002756 | |
| Drug | Leucine enkephalin | 3.23e-05 | 109 | 76 | 5 | CID000003903 | |
| Drug | bromcresol green | 3.38e-05 | 110 | 76 | 5 | CID000006451 | |
| Drug | NSC105014 | 3.38e-05 | 110 | 76 | 5 | CID000001546 | |
| Drug | 2-hydroxyisovaleric acid | 3.69e-05 | 56 | 76 | 4 | CID000099823 | |
| Drug | NSC-218321 | 4.01e-05 | 114 | 76 | 5 | CID000004739 | |
| Drug | resiquimod | 4.18e-05 | 115 | 76 | 5 | CID000159603 | |
| Drug | ridostin | 4.36e-05 | 116 | 76 | 5 | CID011979623 | |
| Drug | rosuvastatin | 4.54e-05 | 59 | 76 | 4 | CID000446157 | |
| Drug | Halt | 4.55e-05 | 21 | 76 | 3 | CID000094635 | |
| Disease | kallikrein-12 measurement | 4.63e-04 | 13 | 73 | 2 | EFO_0008194 | |
| Disease | BMI-adjusted adiponectin measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0007737 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 7.06e-04 | 70 | 73 | 3 | EFO_0008082 | |
| Disease | SLAM family member 7 measurement | 8.02e-04 | 17 | 73 | 2 | EFO_0008287 | |
| Disease | Low Grade Lymphoma (neoplasm) | 1.23e-03 | 21 | 73 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 1.23e-03 | 21 | 73 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 1.23e-03 | 21 | 73 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 1.23e-03 | 21 | 73 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 1.23e-03 | 21 | 73 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 1.23e-03 | 21 | 73 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 1.23e-03 | 21 | 73 | 2 | C0024304 | |
| Disease | Lymphoma, Diffuse | 1.23e-03 | 21 | 73 | 2 | C3714542 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 1.35e-03 | 22 | 73 | 2 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 1.35e-03 | 22 | 73 | 2 | C0079770 | |
| Disease | otitis media (implicated_via_orthology) | 1.35e-03 | 22 | 73 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Cholangiocarcinoma | 1.89e-03 | 26 | 73 | 2 | C0206698 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.19e-03 | 28 | 73 | 2 | DOID:5409 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLYVWINLKKYLDPC | 481 | Q4AC99 | |
| LCPYKKHLEKLKYCW | 66 | Q5NDL2 | |
| GIYTLLTKKYQTWIK | 241 | P49863 | |
| CYRKYKQLTWIALKF | 1081 | O94983 | |
| SLSSYLKEICPKWVK | 131 | Q9BQ75 | |
| SKCKPLWGKVFYLDL | 41 | Q9UBU7 | |
| VKCLLKYSTTWKPLN | 56 | Q9NXF7 | |
| LAKKIFLKYYPRWVA | 726 | P54802 | |
| WMLYCTKKDPDYLKL | 11 | Q6ZS30 | |
| SLVKYFSVVWCKPSK | 121 | Q9Y620 | |
| LILYSKIGYELWIKK | 231 | Q96P65 | |
| IPSYLKCYKWVLKES | 671 | Q86VS3 | |
| KCYKWVLKESSRYGL | 676 | Q86VS3 | |
| IKVKCPYEKVNLSWY | 36 | Q6IE38 | |
| KYICTSFYPWVNILK | 246 | P26045 | |
| KCIVYYKEPFWRKKD | 296 | P27338 | |
| SPEYKAACKLWDLYL | 131 | Q86U86 | |
| YGKQPKLWLCEYCLK | 201 | Q9H7Z6 | |
| KLWLCEYCLKYMKYE | 206 | Q9H7Z6 | |
| TLYLTEKKYSPCAWE | 151 | P01568 | |
| KSYLKRKYLLSSIQW | 151 | Q9NX04 | |
| TLYLTEKKYSPCAWE | 151 | P01562 | |
| NKLLYAKDIPSYKSW | 1796 | O75051 | |
| WKCYLSYVRETKGKL | 101 | Q12996 | |
| TLYLTEKKYSPCAWE | 151 | P01569 | |
| YRVWIQCKYCKPLLS | 361 | Q6P1Q9 | |
| KPGVYTKVCKYVDWI | 261 | Q9UBX7 | |
| KKLCALYGKWTECLY | 766 | Q9BXW6 | |
| VSVKVYYKKCWSIIE | 196 | Q15375 | |
| VYQTLSAKLLWKKYP | 776 | Q969R2 | |
| KATVKARPSVLWCYK | 46 | Q9H0A0 | |
| YKIWKKNTPFLYDLV | 21 | Q09028 | |
| YRVWIQCKYCKPLLS | 361 | Q96IZ6 | |
| GIIKCYHYWPISLKK | 261 | Q4JDL3 | |
| KCYWKSYLVLGIFTL | 86 | O15439 | |
| TWTYSPLLKKLYCQI | 141 | O15350 | |
| ELSQKLYKYCPKEWK | 71 | Q96NE9 | |
| KKYILEWCVLSDKAP | 451 | P40189 | |
| KKVWSALPYTICKDE | 396 | Q9Y625 | |
| SPDPKACNWKKYKYI | 186 | Q8N143 | |
| WGVCKLLKYIKDTYN | 351 | Q9H227 | |
| VPCASVKKLYLKWAL | 431 | P10643 | |
| SATCPQWVYKVAKKY | 326 | Q9BQ39 | |
| LPLCVVLFVYWKIYK | 211 | P47898 | |
| INYKYKTKCTWLIEG | 111 | Q5VV63 | |
| TVAKLWIYPVKSCKG | 56 | Q969Z3 | |
| LYLKEKKYSPCAWEV | 151 | P01563 | |
| ATNLKLKKIYFYWLC | 431 | P04839 | |
| LDWKKMYFKLVRCYP | 291 | Q969P5 | |
| VLEWRVKYSKYKPLS | 51 | Q96MD7 | |
| TLYLTEKKYSPCAWE | 151 | P01571 | |
| LKWKDYNCDAKLPYV | 156 | Q6UW15 | |
| TLYLTEKKYSPCAWE | 151 | P05013 | |
| VGKWCKPYKFATLAT | 266 | Q8TC99 | |
| LKLLPCSYKLWYRYL | 61 | Q9HCS7 | |
| KKWLCEKSGLYEPTF | 221 | Q8TBP6 | |
| LKQLTDPYYLWRKSK | 446 | Q7LBE3 | |
| DPYYLWRKSKLDCCI | 451 | Q7LBE3 | |
| FWISCEEYKKIKSPS | 91 | P49798 | |
| ITAWKYLAKYLKNIL | 346 | Q15573 | |
| PKYCKNLSWSTKYKY | 1641 | Q9NTG1 | |
| KIDAYPWLECFIKSY | 596 | Q9NUX5 | |
| CSPYWIKFKKCIYFI | 726 | Q15858 | |
| AVICVWKEKKKGSYY | 21 | P15907 | |
| DCIWTIKATPKAKIY | 206 | Q8NC67 | |
| TLYLTEKKYSPCAWE | 151 | P05014 | |
| KKTLPELYAFTICLW | 241 | P47972 | |
| VTPFAALLKSIWYKC | 411 | Q9HBY0 | |
| PLKLSKVYFYWICRD | 431 | Q9HBY0 | |
| LYPWKKEFRSIKTYT | 101 | Q9UM82 | |
| PVCKEYLLMKWLAYG | 701 | O75762 | |
| SCKVYYRKLKALWSK | 211 | Q5T0L3 | |
| TSWTGKLCALVYKIK | 1921 | Q15413 | |
| ICDLKYILISKPTIW | 476 | Q8IWV7 | |
| CPYNRKESKSIKYWC | 371 | P01833 | |
| KPYKCNVWKVLKSEF | 816 | Q96SE7 | |
| KAVWPLELAYCLQKY | 116 | Q3LFD5 | |
| ALYGKLLKLPTCWTK | 766 | Q7Z7G8 | |
| KYKSKPFCEKLLSWV | 96 | Q969U7 | |
| ILRKAWKIYNKCYLD | 161 | Q8N584 | |
| GAYKKKNTRVYPCVW | 486 | Q14202 | |
| ELLWKKQIPAYYKIF | 136 | A8MPX8 | |
| KLWKLIAYYSEVPVK | 376 | Q9NR99 |